Introduction Drug discovery thrives on understanding one fundamental question: How strongly do molecules bind? From antibody–antigen recognition to protein–drug interaction, binding kinetics drive every decision in modern biotech. That’s where surface plasmon resonance service providers come in. Using label-free, real-time detection of molecular interactions, SPR gives researchers the kinetic and affinity data that underpin target